Adaptive Biotechnologies ADPT Mrd Business — Cost of Goods Sold

Similar metrics at other companies

TEMDiagnostics — Cost of Goods Sold

$100.96M+19.1%

NOVTMedical Solutions — Cost of Goods Sold

$71.73M+15.6%

TEC

TECHDiagnostics And Spatial Biology — Cost of Goods Sold

$38.65M+3.9%

PLUSManaged Services Reporting Unit — Cost of Goods Sold

$33.25M+10.8%

BRK.AManufacturing Businesses — Cost of Goods Sold

$13.79B+11.8%

AVAVMw — Cost of Goods Sold

$16.36M+11.5%

Questions, answered.

What is Adaptive Biotechnologies's mrd business — cost of goods sold?

Adaptive Biotechnologies (ADPT) reported mrd business — cost of goods sold of $17.24M in Q1 2026.

How has Adaptive Biotechnologies's mrd business — cost of goods sold changed year-over-year?

Adaptive Biotechnologies's mrd business — cost of goods sold increased by 8.6% year-over-year, from $15.89M to $17.24M.

What is the long-term trend for Adaptive Biotechnologies's mrd business — cost of goods sold?

Over 3 years (2022 to 2025), Adaptive Biotechnologies's mrd business — cost of goods sold has grown at a 16.3% compound annual growth rate (CAGR), from $42.61M to $67.03M.

What does mrd business — cost of goods sold mean?

This captures the direct costs incurred to produce and deliver the diagnostic tests and services within the MRD business segment. It includes expenses such as laboratory reagents, personnel costs for testing, and shipping, providing insight into the direct profitability of the segment's operations.